Company Filing History:
Years Active: 2007-2009
Title: Helmut Robert Maecke: Innovator in Somatostatin Analogues
Introduction
Helmut Robert Maecke is a notable inventor based in Loerrach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cancerous diseases through innovative methods involving somatostatin analogues. With a total of 2 patents, Maecke's work is recognized for its potential impact on cancer treatment.
Latest Patents
Maecke's latest patents include a treatment process using somatostatin analogues. This method characterizes a disease by the overexpression of somatostatin receptors and involves exposing these receptors to a pharmaceutical composition that includes a somatostatin analogue. The composition may contain various components, such as DOTA-based chelators, DTPA-based chelators, and other specialized molecules designed to enhance the efficacy of the treatment. Another patent focuses on compositions of somatostatin analogues, detailing the specific chemical structures and components that can be utilized in therapeutic applications.
Career Highlights
Throughout his career, Maecke has worked with prestigious institutions, including the University of Bern and Advanced Accelerator Applications USA, Inc. His research and innovations have contributed to advancements in medical treatments, particularly in oncology.
Collaborations
Maecke has collaborated with various professionals in his field, including Hans Rink, to further his research and development efforts.
Conclusion
Helmut Robert Maecke's contributions to the field of pharmaceuticals, particularly through his patents on somatostatin analogues, highlight his role as an influential inventor. His work continues to pave the way for innovative cancer treatments that may significantly improve patient outcomes.